- Sector Life Sciences
Takeda UK is a wholly owned subsidiary of Japan's largest pharmaceutical company - a global industry leader with more than 30,000 employees in 70 countries.
Our mission is to strive towards better health for people worldwide through leading innovation in medicine. We are proud of our distinguished 230-year heritage, which is rooted in the values of 'Takeda-ism': integrity, fairness, honesty and perseverance.
By applying these principles consistently to everything we do, and by always putting patients' interests first, we aim to earn the trust of the communities we serve. As a values-based, customer-focussed organisation, our goal is to be an agile, best-in-class pharmaceutical company.
We seek to excel areas of high unmet medical need: oncology, gastroenterology and diabetes. In each of these fields, we work towards realising our 'Vision 2025' by giving patients throughout the UK access to innovative new medicines.
Takeda is embarking on the next stage of its evolution into an agile specialty care provider, delivering better health for patients through leading innovations in these therapy areas.
In the UK, Takeda has three organisations:
- Takeda UK, established in High Wycombe in 1997 to commercialise our products in the UK
- Takeda Cambridge, our pre-clinical research division, supplements our R&D network in Japan, Europe and the USA with world-class target identification and validation capabilities
- Takeda Development Centre Europe - with more than 400 employees in the UK, Switzerland and Denmark, TDC was set up in London in 2004 to establish a system for conducting clinical trials and formulating applications for approval for our US and European R&D functions